News

A laboratory setting that showcases extensive peptide research, featuring colorful models and advanced lab equipment  (Adobe Stock 1575751286 By H_Ko)

Bacteria have learned to evade many of our antibiotics. But what about defenses shaped by millions of years of evolution? An experimental peptide derived from the human immune protein CXCL10 targets resistant pathogens by exploiting a distinct bacterial vulnerability. The research is early, but the strategy could have implications far beyond a single drug candidate.

Measles outbreak and vaccination  (Adobe Stock 1971993240 by Ming)

The US effectively eliminated measles once. Now cases are climbing again, infants remain vulnerable, people have died, and vaccine misinformation is undermining one of public health's greatest achievements. The price of forgetting what vaccines prevent can be measured in lives.

Waiting-room roulette: where the patient isn’t the only one hanging around. How 3 bat sightings can grow into a 128-patient, nine-day exposure investigation. Here’s how to be ready before one finds your facility.  (Image by Brenna Doran with AI)

There’s a bat in the hospital. Now what? Before anyone swats it, grabs it, or throws it away, infection prevention needs staff to understand one thing: That bat may be critical evidence in determining whether patients and employees need rabies PEP. One bat. One bad decision. A potentially enormous exposure investigation.

Contagious Conversations

Recent changes from CBIC involving IPUs have opened a much bigger conversation about industry, consultants, commercial bias, continuing education, and professional expertise. In a candid Contagious Conversations discussion, 4 experienced IP professionals ask whether the answer should depend on where an educator works or what that educator actually teaches. It is a conversation the IPC community may need to have sooner rather than later.

Sadé L. Rolon, MBA, CMIP, CHESP, T-CHEST, T-CSCT, the regional director of operations for Sodexo’s Healthcare Division,  Julie Mangino, MD, infectious disease specialist at The Ohio State University Medical Center, Columbus, OH,  James “JJ” Odom, MBA, CHESP, CMIP, T-CHEST, the university director of buildings & grounds at UConn Health, Farmington, Connecticut,  Christopher Dugard, MS, director for the Division of Infection Control Devices in the Office of Surgical and Infection Control Devices, FDA/Center for Devices and Radiological Health.  and Elizabeth “Liz” Claverie, MS, (retired CAPT, 0-6) vice president, regulatory strategic liaison for Steris.  (Image credit: Author)

During an expert panel at Exchange26 on whole-room microbial reduction technologies, regulatory and health care leaders discussed the distinction between FDA and EPA oversight, what constitutes a medical device claim, the risks surrounding unauthorized or off-label claims, and why IP and EVS professionals should verify a device's regulatory status rather than relying solely on vendor presentations.

Donald Sipp, Jr, MBA, RESE, CHESP, CHTI-2, CMIP, PMP, and David Green  (Image credit: author)

“Cutting” waste shouldn’t mean cutting people. At AHE Exchange26, David Green and Donald Sipp explored how EVS departments can improve performance by strengthening workplace culture, empowering employees, eliminating inefficient processes, and understanding EVS’s critical role in patient throughput. One case study showed bed turnaround times falling from nearly 2 hours to less than an hour, but the larger lesson wasn't simply about speed. High-performing EVS operations begin with a strong foundation.

Bug of the Month

The Bug of the Month helps educate readers about existing and emerging pathogens that are clinically important in today's health care facilities. This month’s Bug of the Month isn’t quite like anything we’ve featured before. Can you solve the clues before the final reveal?